• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Horizon Blue Cross Blue Shield seeks for-profit status

Article

Independent, nonprofit Blue plans are becoming extinct

As nonprofit, regional health plans fight the good fight, they find themselves at a disadvantage when competing against the big for-profits. A proposal by Horizon Blue Cross Blue Shield to convert to for-profit status has stirred up unrest with those who advocate for nonprofit healthcare.

The Alliance for Advancing Nonprofit Health Care issued letters to the New Jersey Commissioner of the Department of Banking and Insurance and to the state attorney general, stating that Horizon is in a positive position in its community and that independent consultants should review Horizon’s application and address “critical information gaps” in it.

Horizon is the oldest, largest nonprofit health plan in the state.

A wave of mergers in the past 15 years resulted in major consolidations among Blues plans, making the remaining Blues plans particularly attractive to large MCOs seeking to ratchet up growth. Horizon has not announced any plans to sell or merge, but continued competitive pressure could force its hand.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.